Page last updated: 2024-11-02

pamidronate and Anasarca

pamidronate has been researched along with Anasarca in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Pamidronate (60 mg) was given intravenously on Days 1, 2, 14, 28, and 56, over 4 h in 500 ml of 5% dextrose."2.70Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. ( Aaron, S; Chiu, P; Jhangri, GS; Lambert, R; Leclercq, S; Maksymowych, WP; Russell, AS; Wong, B, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liao, M1
Magcalas, P1
Hopkins-Braddock, P1
Kraenzlin, ME1
Graf, C1
Meier, C1
Kraenzlin, C1
Friedrich, NF1
Lee, R1
Al-Adhoubi, NK1
Jawad, AS1
Maksymowych, WP1
Lambert, R1
Jhangri, GS1
Leclercq, S1
Chiu, P1
Wong, B1
Aaron, S1
Russell, AS1

Trials

1 trial available for pamidronate and Anasarca

ArticleYear
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
    The Journal of rheumatology, 2001, Volume: 28, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Arthritis, Reactive; Blood Sedimentation; Bone Marrow; C-Reactive P

2001

Other Studies

3 other studies available for pamidronate and Anasarca

ArticleYear
Case 4: How Much Is Too Much? A Case of Hypercalcemia in a 6-year-old Boy.
    Pediatrics in review, 2015, Volume: 36, Issue:9

    Topics: Bone Density Conservation Agents; Calcitonin; Child; Diagnosis, Differential; Dietary Supplements; D

2015
Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2010, Volume: 18, Issue:12

    Topics: Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density Conservation Agents; Bone Marrow Diseas

2010
Bone marrow oedema of the radius presenting as tennis elbow.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:2

    Topics: Adult; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Edema; Female; Humans

2013